According to a new report Global Implantable Cardiac Monitors Market, published by KBV research, The Global Implantable Cardiac Monitors Market size is expected to reach $714.4 million by 2024, rising at a market growth of 7.6% CAGR during the forecast period.
The North America market would dominate the Global Cardiac Arrhythmias Market by Region by 2024, growing at a CAGR of 6.3 % during the forecast period. The Europe market is expected to witness a CAGR of 6.7% during (2018 - 2024). Additionally, The Asia Pacific market is expected to witness a CAGR of 8.4% during (2018 - 2024).
The Hospitals market dominated the Global Implantable Cardiac Monitors Market by End User 2017 and would achieve a market value of $459 million by 2024, growing at a CAGR of 7.1 % during the forecast period. The Ambulatory Surgery Centers (ASCs) market is expected to witness a CAGR of 8% during (2018 - 2024).
Full Report: https://www.kbvresearch.com/implantable-cardiac-monitors-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abiomed, Inc., Abbott Laboratories, Boston Scientific Corporation, Reliant Heart, Inc., Astellas Pharma Inc., Biotronik SE & Co. KG, Agilent Technologies, Inc., Berlin Heart GmbH, Schiller AG, Jarvik Heart, Inc.
Global Implantable Cardiac Monitors Market Segmentation
By Indication
By End User
By Geography
Companies Profiled
Unique Offerings from KBV Research
Related Reports:
North America Implantable Cardiac Monitors Market
Europe Implantable Cardiac Monitors Market
Asia Pacific Implantable Cardiac Monitors Market
LAMEA Implantable Cardiac Monitors Market
Unique Offerings 
